Bicara Therapeutics, Inc. (BCAX)
9.73
-0.03
(-0.31%)
USD |
NASDAQ |
Oct 29, 16:00
9.40
-0.33
(-3.39%)
After-Hours: 20:00
Bicara Therapeutics Market Cap : 641.51M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 641.51M |
| October 28, 2026 | 643.49M |
| October 27, 2026 | 1.152B |
| October 26, 2026 | 1.114B |
| October 23, 2026 | 1.125B |
| October 22, 2026 | 1.161B |
| October 21, 2026 | 1.181B |
| October 20, 2026 | 1.210B |
| October 19, 2026 | 1.152B |
| October 16, 2026 | 1.106B |
| October 15, 2026 | 1.162B |
| October 14, 2026 | 1.143B |
| October 13, 2026 | 1.143B |
| October 12, 2026 | 1.143B |
| October 09, 2026 | 1.154B |
| October 08, 2026 | 1.138B |
| October 07, 2026 | 1.083B |
| October 06, 2026 | 1.092B |
| October 05, 2026 | 1.140B |
| October 02, 2026 | 1.162B |
| October 01, 2026 | 1.200B |
| September 30, 2026 | 1.227B |
| September 29, 2026 | 1.224B |
| September 28, 2026 | 1.240B |
| September 25, 2026 | 1.267B |
| Date | Value |
|---|---|
| September 24, 2026 | 1.304B |
| September 23, 2026 | 1.351B |
| September 22, 2026 | 1.502B |
| September 21, 2026 | 1.451B |
| September 18, 2026 | 1.493B |
| September 17, 2026 | 1.489B |
| September 16, 2026 | 1.450B |
| September 15, 2026 | 1.495B |
| September 14, 2026 | 1.530B |
| September 11, 2026 | 1.504B |
| September 10, 2026 | 1.523B |
| September 09, 2026 | 1.559B |
| September 08, 2026 | 1.563B |
| September 04, 2026 | 1.528B |
| September 03, 2026 | 1.539B |
| September 02, 2026 | 1.553B |
| September 01, 2026 | 1.544B |
| August 31, 2026 | 1.524B |
| August 28, 2026 | 1.545B |
| August 27, 2026 | 1.637B |
| August 26, 2026 | 1.630B |
| August 25, 2026 | 1.621B |
| August 24, 2026 | 1.555B |
| August 21, 2026 | 1.576B |
| August 20, 2026 | 1.608B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.537B |
| Oncolytics Biotech, Inc. | 53.31M |
| Sangamo Therapeutics, Inc. | 49.67M |
| Sarepta Therapeutics, Inc. | 2.031B |
| Anixa Biosciences, Inc. | 114.13M |
Market Cap Related Metrics
| PEG Ratio | -0.0495 |
| Price to Book Value | 1.368 |
| Price | 9.73 |
| Earnings Yield | -31.71% |
| PEGY Ratio | -0.0495 |